Experienced in COVID-19

Thijs D. Rettig

Noord, NB, NL 
Experienced in COVID-19
Noord, NB, NL 
OverviewLocationsClinical Research

Overview

Thijs Rettig practices in Noord, Netherlands. Rettig is rated as an Experienced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Acute Respiratory Distress Syndrome (ARDS), Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Their clinical research consists of co-authoring 49 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 11 articles in the study of COVID-19.

Locations

Noord, NB, Netherlands
Other Locations
Breda, NB, Netherlands
Admiraal De Ruyter Ziekenhuis
Goes, ZE, Netherlands
Franciscus Gasthuis & Vlietland
Rotterdam, ZH, Netherlands
The Hague, 2512VA, Netherlands
St. Antonius Hospital Nieuwegein
Nieuwegein, UT, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers During the Perioperative Period: to Withdraw or to Continue? A Multicenter Randomized Controlled Trial
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers During the Perioperative Period: to Withdraw or to Continue? A Multicenter Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: November 29, 2023
Intervention Type: Diagnostic test, Behavioral, Drug
Study Phase: Not Applicable

49 Total Publications

Study protocol of the multicentre, randomised, triple-blind, placebo-controlled MERCURI-2 trial: promoting effective renoprotection in cardiac surgery patients by inhibition of sodium glucose cotransporter (SGLT)-2.
Study protocol of the multicentre, randomised, triple-blind, placebo-controlled MERCURI-2 trial: promoting effective renoprotection in cardiac surgery patients by inhibition of sodium glucose cotransporter (SGLT)-2.
Journal: BMJ open
Published: May 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rettig's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile